Adaptive Deep Brain Stimulation for Parkinson's Disease

This trial aims to improve sleep quality for people with Parkinson's disease who already use adaptive deep brain stimulation (aDBS). Researchers will collect sleep data and test three different aDBS settings to identify the most effective one for better sleep. Participants will use these settings at home and provide feedback, which will help determine the optimal setup. Ideal candidates for this trial have Parkinson's, already use specific DBS equipment, and have maintained stable treatment settings for their motor symptoms for at least a month. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance sleep quality for Parkinson's patients.

Research has shown that adaptive Deep Brain Stimulation (aDBS) is generally safe for people with Parkinson's Disease. Studies have found no serious problems related to the device itself, and most minor issues resolved during the setup and adjustment phases of aDBS.

Additionally, aDBS is well-tolerated over long periods and effectively controls symptoms like tremors and slow movement. This means aDBS can help manage the physical symptoms of Parkinson's without causing significant new issues.

Adaptive Deep Brain Stimulation (aDBS) is unique because it offers a personalized approach to treating Parkinson's Disease. Traditional deep brain stimulation (DBS) delivers continuous electrical impulses to the brain, but aDBS adapts its stimulation in real-time based on the patient's brain activity. This means it can potentially reduce side effects and improve symptom control by only delivering stimulation when needed. Researchers are excited about aDBS because it targets the brain more precisely, which could lead to better outcomes for patients with fewer complications.

Research has shown that adaptive deep brain stimulation (aDBS), which participants in this trial will receive, holds promise for treating Parkinson's disease. Studies have found that aDBS can improve movement symptoms by up to 66%, allowing patients better control over their movements. Patients using aDBS also experience more "on-time," periods when their symptoms are well-managed, and they face fewer side effects compared to continuous deep brain stimulation (cDBS). Some reports mention that aDBS enhances overall well-being and movement. However, some studies have not found a significant short-term benefit of aDBS over cDBS. Despite this, the ability to personalize aDBS settings offers hope for better managing Parkinson’s symptoms.⁶⁷⁸⁹¹⁰